alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)]-beta-D-Glcp

Term ID

CHEBI:147863

Synonyms

(2S,3S,4R,5S,6S)-2-[(2R,3R,4S,5R,6R)-2,5-dihydroxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol
6-deoxy-alpha-L-galacto-hexopyranosyl-(1->2)-[beta-D-galacto-hexopyranosyl-(1->3)]-beta-D-gluco-hexopyranose
6-deoxy-alpha-L-galactopyranosyl-(1->2)-[beta-D-galactopyranosyl-(1->3)]-beta-D-glucopyranose
alpha-L-fucopyranosyl-(1->2)-[beta-D-galactopyranosyl-(1->3)]-beta-D-glucopyranose
Fuc(a1-2)[Gal(b1-3)]b-Glc

Definition

A branched trisaccharidethat is α-L-fucopyranosyl-(1→2)-β-D-glucopyranose in which the hydroxy group at position 3 of the glucopyranose moiety has been converted into the corresponding β-D-galactopyranosyl derivative.

References

glygen:G18232WJ
glytoucan:G18232WJ

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)]-beta-D-Glcp

Phenotype where environments contain alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)]-beta-D-Glcp

Phenotype modified by environments containing alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)]-beta-D-Glcp

Phenotype affecting alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)]-beta-D-Glcp

Human Disease Model